Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tannahill

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Neuroendocrinology|October 1, 1992
Dexamethasone and aldosterone modulate corticotropin-releasing factor-41 release from cultured rat fetal hypothalamic cells through type II and type I corticosteroid receptors respectivelyS B Hu, L A Tannahill, S L Lightman
Journal of Neuroimmunology|September 1, 1992
Interleukin-1 beta induces corticotropin-releasing factor-41 release from cultured hypothalamic cells through protein kinase C and cAMP-dependent protein kinase pathwaysS B Hu, L A Tannahill, S L Lightman
The Journal of Endocrinology|April 1, 1991
Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampusL A Tannahill, W J Sheward, I C Robinson, et al.
The Journal of Endocrinology|January 1, 1992
Release of corticotrophin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of intracellular second messengers and to corticosteroidsS B Hu, L A Tannahill, S Biswas, et al.
Neuroscience Letters|June 24, 1985
Different patterns of molecular forms of somatostatin are released by the rat median eminence and hypothalamusA R Pierotti, A J Harmar, L A Tannahill, et al.
BMJ (Clinical Research Ed.)|December 16, 1995
Health checks and coronary risk: further evidence from a randomised controlled trialP Hanlon, J McEwen, L Carey, et al.
Neuroendocrinology|December 1, 1988
Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal bloodL A Tannahill, R C Dow, K M Fairhall, et al.
Occupational Medicine (Oxford, England)|January 11, 2000
Do health checks cause stress?M P Kelly, L Carey, P Hanlon, et al.
The British Journal of Surgery|March 2, 2011
Methylation profiling of rectal cancer identifies novel markers of early-stage diseaseK J Leong, W Wei, L A Tannahill, et al.
Clinical Endocrinology|June 20, 2002
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumoursL A Tannahill, T J Visser, C J McCabe, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Neuroendocrinology|October 1, 1992
Dexamethasone and aldosterone modulate corticotropin-releasing factor-41 release from cultured rat fetal hypothalamic cells through type II and type I corticosteroid receptors respectivelyS B Hu, L A Tannahill, S L Lightman
Journal of Neuroimmunology|September 1, 1992
Interleukin-1 beta induces corticotropin-releasing factor-41 release from cultured hypothalamic cells through protein kinase C and cAMP-dependent protein kinase pathwaysS B Hu, L A Tannahill, S L Lightman
The Journal of Endocrinology|April 1, 1991
Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical stimulation of the hypothalamus, amygdala and hippocampusL A Tannahill, W J Sheward, I C Robinson, et al.
The Journal of Endocrinology|January 1, 1992
Release of corticotrophin-releasing factor-41, arginine vasopressin and oxytocin from rat fetal hypothalamic cells in culture: response to activation of intracellular second messengers and to corticosteroidsS B Hu, L A Tannahill, S Biswas, et al.
Neuroscience Letters|June 24, 1985
Different patterns of molecular forms of somatostatin are released by the rat median eminence and hypothalamusA R Pierotti, A J Harmar, L A Tannahill, et al.
BMJ (Clinical Research Ed.)|December 16, 1995
Health checks and coronary risk: further evidence from a randomised controlled trialP Hanlon, J McEwen, L Carey, et al.
Neuroendocrinology|December 1, 1988
Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal bloodL A Tannahill, R C Dow, K M Fairhall, et al.
Occupational Medicine (Oxford, England)|January 11, 2000
Do health checks cause stress?M P Kelly, L Carey, P Hanlon, et al.
The British Journal of Surgery|March 2, 2011
Methylation profiling of rectal cancer identifies novel markers of early-stage diseaseK J Leong, W Wei, L A Tannahill, et al.
Clinical Endocrinology|June 20, 2002
Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumoursL A Tannahill, T J Visser, C J McCabe, et al.
Pageof 3